Cumberland Pharmaceuticals (CPIX) Reports Q3 Loss of $0.11

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q3 EPS of ($0.11), versus ($0.05) reported last year. Revenue for the quarter came in at $8.5 million versus the consensus estimate of $9.16 million.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• Worthington Steel, Inc. (WS) Misses Q4 EPS by 3c
• Colony Bankcorp to acquire First Reliance in $163M stock-and-cash deal
• H.B. Fuller (FUL) Tops Q2 EPS by 3c; Offers Outlook